lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
5,459 rows where filing_period = "second_quarter" and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3371996 | GRANITE CAPITOL CONSULTING LLC c0876b52-84e1-42f3-868f-811ee9c9c187 | Q2 | GRANITE CAPITOL CONSULTING LLC | 401108946 | QURALIS | 2025 | second_quarter | MED | FDA Related Issues | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2025-05-05T15:56:17-04:00 | |
| 3375445 | OCAL LOBBYING GROUP 571ad10d-4c01-44fa-a6e2-18a1714c9469 | Q2 | OCAL LOBBYING GROUP | 401106825 | SAMERA S.A. | 2025 | second_quarter | MED | Planning for year end project initiative | 0 | 0 | 2025-06-30T12:54:11-04:00 | |||
| 3375446 | OCAL LOBBYING GROUP d6f55022-1313-4c0e-9fa8-d63a7fc160c1 | Q2 | OCAL LOBBYING GROUP | 401106825 | BR.MANNESMAN TECHNOLOGY | 2025 | second_quarter | MED | TB Research | 0 | 0 | 2025-06-30T12:59:15-04:00 | |||
| 3375470 | AUBURN HEALTH STRATEGIES, LLC 028efe34-83a6-467c-bbd3-67507a626929 | Q2 | AUBURN HEALTH STRATEGIES, LLC | 292697 | AMERICAN PROFICIENCY INSTITUTE | 2025 | second_quarter | MED | proficiency testing for clinical laboratories | Health & Human Services, Dept of (HHS),SENATE | 0 | 0 | 2025-06-30T15:38:56-04:00 | ||
| 3375495 | HARPER DOWNING b0e50b1e-d9dd-438a-9005-37d1d933f88d | Q2 | HARPER DOWNING | 401107879 | HUMANETICS CORPORATION | 2025 | second_quarter | MED | FY26 Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2025-06-30T17:39:04-04:00 | |
| 3375531 | MCDERMOTT+ LLC 4104d1d8-b3fc-4fe1-9ead-8e3998931f2b | Q2 | MCDERMOTT+ LLC | 401103287 | VERILY LIFE SCIENCES LLC | 2025 | second_quarter | MED | Efforts relating to artificial intelligence, wastewater surveillance, and drug device innovation. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2025-07-01T09:40:30-04:00 | |
| 3376014 | FLORIDA STATE UNIVERSITY 0ebd1b56-2e48-40d9-993f-fc265dc96bb2 | Q2 | FLORIDA STATE UNIVERSITY | 14952 | FLORIDA STATE UNIVERSITY | 2025 | second_quarter | MED | NIH Cancellations MAHA Initiatives | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 98000 | 0 | 0 | 2025-07-02T09:17:40-04:00 | |
| 3376052 | CAPSTONE NATIONAL PARTNERS 65ff7cae-aa9d-4259-9f22-d9a32da0c952 | Q2 | CAPSTONE NATIONAL PARTNERS | 8214 | ATTERX BIOTHERAPEUTICS | 2025 | second_quarter | MED | FY26 Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2025-07-02T10:33:24-04:00 | |
| 3376151 | REPUBLIC CONSULTING, LLC b26f63f8-f15c-444e-93e5-f8392a7b6f8f | Q2 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2025 | second_quarter | MED | Monitor health data budgets and policy. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2025-07-02T13:51:05-04:00 | |
| 3376568 | RAY C CULVER III d5e5a65a-5229-43fa-9f56-5aa3699165da | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2025 | second_quarter | MED | USDA ARS Human Nutrition Research funding in FY2025 Full-Year Continuing Appropriations and Extensions Act, P.L. 119-4, and FY2026 Agriculture Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2025-07-03T16:59:19-04:00 | |
| 3376928 | CANNON|PEARCE FKA MR. MATT PEARCE 1ac65a6a-daaa-486e-9eda-ba5e1236da97 | Q2 | CANNON|PEARCE FKA MR. MATT PEARCE | 401108148 | SIMVANA | 2025 | second_quarter | MED | Medical education and training | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2025-07-06T17:54:06-04:00 | |
| 3377045 | AMERICAN COLLEGE OF CLINICAL PHARMACY 913d64ec-b0a8-4867-950e-eb53eca1f3cb | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2025 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2025-07-07T11:10:51-04:00 | |
| 3377529 | MASON STREET CONSULTING, LLC f928a9d7-f7d6-4f96-a02f-e7b562f38ac7 | 2T | MASON STREET CONSULTING, LLC | 401105150 | PERIMETER MEDICAL IMAGING | 2025 | second_quarter | MED | Advanced Research Projects Agency for Health (ARPA-H). | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 1 | 2025-07-08T11:18:43-04:00 | |
| 3377829 | IMPACT MANAGEMENT GROUP cdeb9d6e-3c96-48f4-a2b8-272b37a42519 | Q2 | IMPACT MANAGEMENT GROUP | 401104137 | ARKANSAS RESEARCH ALLIANCE | 2025 | second_quarter | MED | On behalf of client support continued and future funding for clinical research programs in Arkansas | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2025-07-08T15:56:15-04:00 | ||
| 3377830 | IMPACT MANAGEMENT GROUP 24df160f-6820-4036-b58e-adbcbad7e5f6 | Q2 | IMPACT MANAGEMENT GROUP | 401104137 | CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. | 2025 | second_quarter | MED | On behalf of Client support continued and future funding for CARTI in Arkansas | HOUSE OF REPRESENTATIVES | 0 | 0 | 2025-07-08T15:56:56-04:00 | ||
| 3377947 | THE HARRIS FIRM 4f3e2ec2-bf3e-4d83-927c-c5ffdf1e8402 | Q2 | THE HARRIS FIRM | 68376 | HOLISTIC INDUSTRIES INC. | 2025 | second_quarter | MED | Issues pertaining to cannabis CSA scheduling. | Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE | 50000 | 0 | 0 | 2025-07-08T21:00:19-04:00 | |
| 3378094 | MAGILL ASSOCIATES, LLC 297f1e79-51cd-4005-ab37-f6206f5c9be9 | Q2 | MAGILL ASSOCIATES, LLC | 401103511 | THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | 2025 | second_quarter | MED | FY 2026 appropriations for the development of a synthetic vaccine | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2025-07-09T10:41:09-04:00 | ||
| 3378177 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 843407e9-1360-4399-af60-9506ee25b5c0 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | HAZELDEN BETTY FORD FOUNDATION | 2025 | second_quarter | MED | Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Servicemembers and Veterans. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-07-09T11:34:28-04:00 | |
| 3378184 | VENABLE LLP 7203da4a-5a76-4531-b6c3-b4e929279094 | Q2 | VENABLE LLP | 39941 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2025 | second_quarter | MED | NIH reform proposals S.Res.173, World Malaria Day resolution State Department reauthorization | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2025-07-09T11:37:50-04:00 | |
| 3378262 | CORNERSTONE GOVERNMENT AFFAIRS, INC. e3d68c59-8901-4aad-bed5-24b75161a758 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MMV MEDICINES FOR MALARIA VENTURE | 2025 | second_quarter | MED | The purpose was to increase funding for malaria research in the Department of Defense. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-07-09T12:52:24-04:00 | |
| 3378348 | CORNERSTONE GOVERNMENT AFFAIRS, INC. ed472333-17a2-4ed1-ab0d-241e23f776f1 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | ADVANCED MATERIALS AND DEVICES, INC. | 2025 | second_quarter | MED | Educated key government stakeholders on AMADs products applicable to the military and supported appropriations requests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2025-07-09T13:32:39-04:00 | |
| 3378351 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 2d1cbacf-b163-4881-b46d-26af665c0cd2 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ | 2025 | second_quarter | MED | Educated key government stakeholders on the University's medical capabilities in areas applicable to military health and readiness. Supported Defense authorizations and appropriations. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-09T13:35:01-04:00 | |
| 3378355 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 96922b2a-44e8-4d67-abe2-130ecb5c93d9 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE GENEVA FOUNDATION | 2025 | second_quarter | MED | Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2025-07-09T13:38:08-04:00 | |
| 3378358 | CORNERSTONE GOVERNMENT AFFAIRS, INC. ec6ad2cb-0fb7-4c50-a27c-6091e0baeae8 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | WASHINGTON STATE UNIVERSITY | 2025 | second_quarter | MED | Educated key government stakeholders on WSUs research and development activities in support of US Service members; support Defense appropriations. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-07-09T13:39:54-04:00 | |
| 3378413 | SQUIRE PATTON BOGGS 6e1b8691-2774-4d25-81f1-4851293f6f56 | Q2 | SQUIRE PATTON BOGGS | 30906 | LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. | 2025 | second_quarter | MED | Funding support for federally qualified health centers; reauthorization of programs | 20000 | 0 | 0 | 2025-07-09T14:30:46-04:00 | ||
| 3378463 | FEDERAL SOLUTIONS, LLC 648bab8b-8c41-4287-914a-4ecbc5392fc9 | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2025 | second_quarter | MED | Labor/HHS/Education Appropriations: Provisions relating to disease research | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-07-09T15:06:08-04:00 | |
| 3378886 | CORNERSTONE GOVERNMENT AFFAIRS, INC. c12501b2-2427-461f-9ad9-5a3b0c59808a | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE UNIVERSITY OF TEXAS SYSTEM | 2025 | second_quarter | MED | Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities. | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2025-07-10T11:09:24-04:00 | |
| 3379134 | DARTMOUTH-HITCHCOCK MEDICAL CENTER 9f88b353-3f52-4a5c-b677-8abdf9418dc1 | Q2 | DARTMOUTH-HITCHCOCK MEDICAL CENTER | 40014114 | DARTMOUTH-HITCHCOCK MEDICAL CENTER | 2025 | second_quarter | MED | Grant management, including funding status | 10000 | 0 | 0 | 2025-07-10T14:04:23-04:00 | ||
| 3379421 | THE LIVINGSTON GROUP, LLC 31126042-4045-4460-9b48-b0e3c2df44ad | Q2 | THE LIVINGSTON GROUP, LLC | 49635 | INNOVATIVE VACCINE TECHNOLOGIES | 2025 | second_quarter | MED | FY2026 appropriations for the development of a synthetic vaccine | 0 | 0 | 2025-07-10T15:48:12-04:00 | |||
| 3379895 | ACORN CONSULTING 7daa2916-9ce7-4dd6-8129-6f4beaf6e369 | Q2 | ACORN CONSULTING | 401107972 | THORAGENIX INNOVATIONS, INC. | 2025 | second_quarter | MED | Advancing study and approval for medical devices | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-11T11:30:01-04:00 | |
| 3380036 | THE PETRIZZO GROUP, INC. 8b5bcf83-ce67-41d5-9d43-b672d7c37492 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION | 2025 | second_quarter | MED | Increased funding for pediatric medical research | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2025-07-11T13:25:01-04:00 | |
| 3380142 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 26b00985-c12c-4878-b586-2483d9a40208 | Q2 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) | 401103161 | UNIVERSITY OF MARYLAND, BALTIMORE (UMB) | 2025 | second_quarter | MED | NONE | 10000 | 0 | 0 | 2025-07-11T15:27:35-04:00 | ||
| 3380210 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) f875105f-ecdd-492f-8511-0cee5d5dfd61 | Q2 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2025 | second_quarter | MED | * ADLM wrote letters to HHS Secretary Kennedy separately, and jointly, urging the reinstatement of the Clinical Laboratory Improvement Advisory Committee * ADLM wrote letters to HHS Secretary Kennedy separately, and jointly, urging the reinstatement of the Advisory Committee on Heritable Disorders in Newborns and Children * ADLM joined with other healthcare groups in urging HHS Secretary Kennedy to not appeal a federal court decision in ACLA vs FDA that ruled the agency did not have statutory authority over laboratory developed tests | Health & Human Services, Dept of (HHS) | 150000 | 0 | 0 | 2025-07-11T16:05:53-04:00 | |
| 3380406 | CHAMBER HILL STRATEGIES 020a7819-b979-4c7c-870c-656bebf094c3 | Q2 | CHAMBER HILL STRATEGIES | 400645947 | SANFORD HEALTH | 2025 | second_quarter | MED | Issues impacting diagnostics including FDA regulation of laboratory developed tests; S 1546/HR 3152, the Patent Eligibility Restoration Act of 2025 | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2025-07-12T15:06:06-04:00 | |
| 3380413 | CHAMBER HILL STRATEGIES e16ba071-faaa-4c8a-9cc2-95dee161aad2 | Q2 | CHAMBER HILL STRATEGIES | 400645947 | MAYO COLLABORATIVE SERVICES, INC. | 2025 | second_quarter | MED | Issues impacting diagnostics including FDA regulation of laboratory developed tests | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2025-07-12T15:16:04-04:00 | |
| 3380750 | THE STATE UNIVERSITY OF NEW YORK, SYSTEM ADMINISTRATION dc7ca6d1-92da-4e35-9cc9-6b9beca5a52e | Q2 | THE STATE UNIVERSITY OF NEW YORK, SYSTEM ADMINISTRATION | 319118 | THE STATE UNIVERSITY OF NEW YORK, SYSTEM ADMINISTRATION | 2025 | second_quarter | MED | indirect cost allocations for federal grants Medicaid | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-07-14T08:31:37-04:00 | |
| 3381149 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 70a8c092-7291-413d-8541-b870f8c44ffe | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | VOCXI HEALTH | 2025 | second_quarter | MED | Educated policymakers and key government stakeholders on VOCxi Health research and development activities in support of US Service members. Requested appropriations funding in the Defense Appropriations bill. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2025-07-14T11:55:04-04:00 | |
| 3381976 | CURE SMA ce6e73df-cbdb-46f9-a4e4-43ce7fed66fd | Q2 | CURE SMA | 401104586 | CURE SMA | 2025 | second_quarter | MED | medical research in spinal muscular atrophy, National Institutes of Health funding, U.S. Department of Defense peer reviewed research in spinal muscular atrophy, Medical Research for Our Troops Act (H.R. 3906) | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 75000 | 0 | 0 | 2025-07-14T16:19:20-04:00 | |
| 3382023 | F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 8401dcc5-3748-4d6d-b616-133f51f0e76c | Q2 | F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES | 18411 | F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES | 2025 | second_quarter | MED | (MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzheimer's and Influenza Preparedness | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2025-07-14T16:44:03-04:00 | |
| 3382053 | GREATER CLEVELAND PARTNERSHIP 9a2baefd-9d15-4e33-81bc-02cae3d39170 | Q2 | GREATER CLEVELAND PARTNERSHIP | 82330 | GREATER CLEVELAND PARTNERSHIP | 2025 | second_quarter | MED | Discussed the importance and impact of funding for innovation and research, especially as it relates to NIH investments | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 90000 | 0 | 0 | 2025-07-14T16:46:25-04:00 | |
| 3382248 | TSG ADVOCATES DC, LLC 23cad68d-fbb2-4c65-afe3-1e0466b3385f | Q2 | TSG ADVOCATES DC, LLC | 401109292 | THE NEMOURS FOUNDATION | 2025 | second_quarter | MED | Healthcare and Medicaid | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2025-07-14T19:41:04-04:00 | |
| 3382265 | BALLARD PARTNERS 9148481e-0058-4a70-a6b6-bacad6ee0a94 | Q2 | BALLARD PARTNERS | 401104288 | BIOSTAR MEDICAL LLC | 2025 | second_quarter | MED | Promoting the advancement of healthcare technology. | 200000 | 0 | 0 | 2025-07-14T20:28:47-04:00 | ||
| 3382347 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 6f781b4f-664b-447e-bc54-b64c1a8e1f49 | 2A | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | HAZELDEN BETTY FORD FOUNDATION | 2025 | second_quarter | MED | Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Servicemembers and Veterans. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-07-15T00:30:32-04:00 | |
| 3382383 | AMERICAN SOCIETY OF ADDICTION MEDICINE 0f28227c-7c96-4f06-8b9f-46df46c2c30f | Q2 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2025 | second_quarter | MED | Joined coalition letters/sent letters to/lobbied Congress, urging them to protect Medicaid for individuals with mental health conditions and substance use disorders, in connection with the One Big Beautiful Bill Act. Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Sent a letter to DOJ regarding amending DEA regulations to allow qualified practitioners to prescribe methadone for OUD for pharmacy administration/dispensing. Sent a letter to OMB, advocating for the streamlining of regulations that hinder innovation in public health and safety approaches that could meaningfully impact access to addiction treatment, including: (1) streamlining regulations to increase access to addiction treatment medications; and (2) reducing prescribing barriers that disincentivize clinicians from prescribing addiction treatment medications. Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Participated in Congressional briefing on the financial sustainability of addiction treatment services. In coalition with the Mental Health Liaison Group, joined a letter urging members of the House Energy & Commerce Committee to pass the SUPPORT for Patients and Communities Reauthorization Act of 2025 (H.R. 2483) out of committee. Sent a letter to Health and Human Services (HHS) Secretary Robert F. Kennedy… | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 30000 | 0 | 0 | 2025-07-15T08:31:54-04:00 | |
| 3382809 | TEAM HALLAHAN LLC 83aa787b-31f5-4ea4-9de5-84ad77cea184 | Q2 | TEAM HALLAHAN LLC | 401104228 | THE ROOSEVELT GROUP (ON BEHALF OF LSU HEALTH SCIENCES FOUNDATION) | 2025 | second_quarter | MED | Research and development efforts and FY 26 Appropriations inside the DOD, HHS/NIH, VA. PACT Act Implementation; community project funding for high performance computing center. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2025-07-15T11:50:21-04:00 | ||
| 3382837 | THE JACKSON LABORATORY 820b2988-676b-4e07-ad4e-9bf0d4aad780 | Q2 | THE JACKSON LABORATORY | 401104723 | THE JACKSON LABORATORY | 2025 | second_quarter | MED | Issues related to biomedical research. Animal model use in biomedical research. | HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE | 30000 | 0 | 0 | 2025-07-15T11:57:58-04:00 | |
| 3382990 | WOODLAND RESOURCES a4d1204b-e928-40a9-ad22-5f14a38cc9f7 | Q2 | WOODLAND RESOURCES | 401108173 | NATIONAL COUNCIL OF YOUTH SPORTS | 2025 | second_quarter | MED | We are having discussions about funding for youth sports injury prevention. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2025-07-15T12:52:14-04:00 | |
| 3383025 | BALLARD PARTNERS 4ac07064-78b5-4c70-aa02-5a5e6912a161 | Q2 | BALLARD PARTNERS | 401104288 | EXTHERA MEDICAL CORPORATION | 2025 | second_quarter | MED | Guidance and advocacy related to procurement approval from the VA and DoD health systems. | Health & Human Services, Dept of (HHS) | 60000 | 0 | 0 | 2025-07-15T13:12:53-04:00 | |
| 3383027 | EFB ADVOCACY, LLC 7a780cca-6cb9-4c76-877d-a4145ebcf697 | Q2 | EFB ADVOCACY, LLC | 401104430 | ASSOCIATION OF AMERICAN CANCER INSTITUTES | 2025 | second_quarter | MED | Issues related to biomedical research National Institutes of Health appropriations funding | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 22500 | 0 | 0 | 2025-07-15T13:16:51-04:00 | |
| 3383053 | EFB ADVOCACY, LLC b7095bbe-2661-4ba8-b361-eae6452b3c52 | Q2 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2025 | second_quarter | MED | Funding Issues related to the National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-15T13:28:30-04:00 | |
| 3383206 | DANA-FARBER CANCER INSTITUTE cba7b003-5b50-41bc-a3fa-4b5c67c0588a | Q2 | DANA-FARBER CANCER INSTITUTE | 401106163 | DANA-FARBER CANCER INSTITUTE | 2025 | second_quarter | MED | Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act | HOUSE OF REPRESENTATIVES,SENATE | 92026 | 0 | 0 | 2025-07-15T14:36:44-04:00 | |
| 3383303 | THORN RUN PARTNERS 29e24bd2-8bc3-4bbd-b5a0-3dfd41119e79 | Q2 | THORN RUN PARTNERS | 400534596 | CONTINUING MEDICAL EDUCATION COALITION | 2025 | second_quarter | MED | Issues related to provision of continuing medical education. | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2025-07-15T15:12:48-04:00 | |
| 3383579 | BALLARD PARTNERS d765acbd-acec-4f74-8e93-1da5985f9265 | Q2 | BALLARD PARTNERS | 401104288 | INSIGHTEC, INC. | 2025 | second_quarter | MED | Guidance on legislation and regulations regarding medical devices; advocacy regarding the use of medical devices at the VA. | Veterans Affairs, Dept of (VA) | 90000 | 0 | 0 | 2025-07-15T16:43:07-04:00 | |
| 3383945 | OLD NORTH STRATEGIES, LLC 9ad6445c-ff94-423d-8ed5-cf90a1b81f34 | Q2 | OLD NORTH STRATEGIES, LLC | 401106174 | EXELA PHARMA SCIENCES, LLC | 2025 | second_quarter | MED | R&D of meds | HOUSE OF REPRESENTATIVES,SENATE | 138000 | 0 | 0 | 2025-07-16T08:17:55-04:00 | |
| 3384072 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) c47eabf6-2187-46ce-b269-17be45ec1854 | Q2 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | INTUITIVE SURGICAL, INC. | 2025 | second_quarter | MED | Lobbying related to health care issues. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2025-07-16T09:27:57-04:00 | |
| 3384125 | BALLARD PARTNERS 424daf1c-046b-4fea-8102-a77cec777eb5 | Q2 | BALLARD PARTNERS | 401104288 | LIFESCIENCE LOGISTICS | 2025 | second_quarter | MED | Government stockpile storage. | Health & Human Services, Dept of (HHS) | 80000 | 0 | 0 | 2025-07-16T09:46:09-04:00 | |
| 3384174 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 33bf8240-cb08-4e38-b481-674d7da1eb3d | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CITY OF HOPE MEDICAL CENTER | 2025 | second_quarter | MED | Issues related to Medicare/Medicaid reimbursement and clinical research. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-07-16T09:55:44-04:00 | |
| 3384556 | UNIVERSITY OF CALIFORNIA 897a3f2a-70a5-4109-861e-4d33a7e5ff77 | Q2 | UNIVERSITY OF CALIFORNIA | 39358 | UNIVERSITY OF CALIFORNIA | 2025 | second_quarter | MED | Supplemental Guidance to the 2024 NIH (National Institutes of Health) Grants Policy Statement: Indirect Cost Rates (NOT-OD-25-068, February 7, 2025); Facilities and Administrative Costs related issues Updated NIH Policy on Foreign Subawards (NOT-OD-25-104, May 1, 2025); grant related issues FY 2026 Departments of Labor, Health and Human Services (HHS), and Education, and Related Agencies Appropriations Act; NIH grants; research and development issues | HOUSE OF REPRESENTATIVES,SENATE | 970000 | 0 | 0 | 2025-07-16T11:35:40-04:00 | |
| 3385210 | GABBERT CONSULTING CO LLC 9885c100-10ba-43a9-a67f-b02aa4e74f85 | Q2 | GABBERT CONSULTING CO LLC | 401105309 | CHIPPS, CAFFREY AND DUBILIER, P. S. C. | 2025 | second_quarter | MED | Lobbyed against medicaid cuts in the Big Beautiful Bill | HOUSE OF REPRESENTATIVES,SENATE | 9000 | 0 | 0 | 2025-07-16T13:51:29-04:00 | |
| 3385297 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 614c7085-3d88-48bb-9e4f-3577cc4e2831 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | GINKGO BIOWORKS, INC. | 2025 | second_quarter | MED | Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, biomanufacturing, and cell engineering; support authorization language and appropriations for Defense and Labor, Health, Human Services and Education. | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2025-07-16T14:03:51-04:00 | |
| 3385396 | AMERICAN PHYSICAL THERAPY ASSOCIATION b997d248-ac98-4f9d-9041-f708ebb7d764 | Q2 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2025 | second_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 301389 | 0 | 0 | 2025-07-16T14:19:02-04:00 | |
| 3385455 | AMERICAN PHYSICAL THERAPY ASSOCIATION cc0a3895-f020-4340-8081-d5aad0e68e8a | 2A | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2025 | second_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 318889 | 0 | 0 | 2025-07-16T14:25:26-04:00 | |
| 3385463 | CORNERSTONE GOVERNMENT AFFAIRS, INC. fedafb53-2b6a-4176-9c9a-257a0ea27e71 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | AMERICAN SOCIETY FOR RADIATION ONCOLOGY | 2025 | second_quarter | MED | Discussions regarding patient access to radiation oncology. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES | 50000 | 0 | 0 | 2025-07-16T14:26:13-04:00 | |
| 3386225 | BALLARD PARTNERS ec63dc10-641b-4e07-8f4b-115e688de41d | Q2 | BALLARD PARTNERS | 401104288 | NOVAVAX, INC. | 2025 | second_quarter | MED | Guidance navigating vaccine policy. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2025-07-16T16:12:23-04:00 | |
| 3386346 | HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. dc51bee1-4512-4301-a0b1-90bc3bcd888d | Q2 | HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. | 52925 | HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. | 2025 | second_quarter | MED | HR 2319/S 1157 - Women and Lung Cancer Research and Preventative Services Act of 2025 All provisions This bill requires a review of women and lung cancer. S. 1320 - Servicewomen and Veterans Menopause Research Act All provisions This bill directs the Secretary of Defense and the Secretary of Veterans Affairs to take certain steps regarding research related to menopause, perimenopause, or mid-life womens health. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2025-07-16T16:39:20-04:00 | |
| 3386401 | IPOLICY SOLUTIONS 157167f8-da67-480c-b56f-5ef05b83e65b | Q2 | IPOLICY SOLUTIONS | 401105127 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2025 | second_quarter | MED | No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HR 1463: Freedom for Laboratory Innovation and Testing Act | HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 70500 | 0 | 0 | 2025-07-16T16:47:46-04:00 | |
| 3386630 | IPOLICY SOLUTIONS 69181b19-8269-4bc8-a6a8-7578fd753c15 | Q2 | IPOLICY SOLUTIONS | 401105127 | ASSOCIATION FOR FRONTOTEMPORAL DEGENERATION | 2025 | second_quarter | MED | Medical research workforce issues Facility and Administrative Costs | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2025-07-16T17:21:30-04:00 | |
| 3386671 | AMERICAN CLINICAL LABORATORY ASSN ec003539-299f-4f43-94c7-42882baba0fb | Q2 | AMERICAN CLINICAL LABORATORY ASSN | 1923 | AMERICAN CLINICAL LABORATORY ASSN | 2025 | second_quarter | MED | Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule; laboratory test coding, pricing, coverage, and payment; implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostic regulatory reform; artificial intelligence in laboratory services; utilization management, including prior authorization policies impacting clinical laboratories. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 450000 | 0 | 0 | 2025-07-16T17:32:51-04:00 | |
| 3386753 | NATIONAL NURSES UNITED 70894ae0-480d-4412-b5d5-83a4f292d618 | Q2 | NATIONAL NURSES UNITED | 40021153 | NATIONAL NURSES UNITED | 2025 | second_quarter | MED | H.R.1 Oppose the budget reconciliation legislation titled, One Big Beautiful Bill Act. Oppose federal workforce pay and benefits cuts, and Medicaid cuts in final budget reconciliation legislation; supported the AFL-CIO led letter opposing AI State law preemption in reconciliation bill. Signed on and supported letter from Center for Health and Democracy opposing health care cuts in the Big Beautiful Bill Act and encouraged House and Senate members to focus on over payments to private insurance offering Medicare Advantage Support Families USA-led organizational sign on letter opposing reconciliation bill Support AFL-CIO led letter opposing AI State law preemption in reconciliation bill, and oppose provision in bill. H.R. 1732 Support GUARD Veterans Health Care Act to protect VA funding from going into the private sector H.R. 20 Support Richard L. Trumka Protecting the Right to Organize Act H.R. 2531 Support Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 2550 Support Protect Americas Workforce Act to restore federal collective bargaining rights H.R. 2753 Support Hands off Medicaid and SNAP Act H.R. 3069 Support Medicare for All Act; discussed NNU opposition to cuts to health care programs in proposed reconciliation bill. H.R. 3178 Oppose The Save Healthcare Workers Act H.R. 3261 Support the VA Employee Fairness Act of 2025 H.R. 3415 Support Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act of 2025 H.R. 3944 Expressed opposition to the Military Construction, Veterans Affairs, and Related Agencies Appropriations Act H.R. 593 Discussed concerns with messaging for strengthening Strengthening Pathways to Health Professions Act, and proposals that we agreed with in the legislation S. 1232 Support Workplace Violence Prevention for Health Care and Social Service Workers Act S. 1506 Support for Medicare for All Act; discussed NNU opposition to cuts to health care programs in proposed reconciliation bill. S. 1650 Support the VA Employee Fairness Act of 2025 S. 1709 Su… | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Occupational Safety & Health Administration (OSHA),Office of Personnel Management (OPM),SENATE | 90000 | 0 | 0 | 2025-07-16T18:14:42-04:00 | |
| 3387162 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 40b581be-028e-4102-b5cb-4c5454fcaff4 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM | 2025 | second_quarter | MED | Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2025-07-16T23:16:16-04:00 | |
| 3387170 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 08eec0bd-b29c-4d66-93ed-194a90e42805 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | NIRSENSE, LLC (FKA BIONICA LABS) | 2025 | second_quarter | MED | Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations and authorization requests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-16T23:27:42-04:00 | |
| 3387178 | CORNERSTONE GOVERNMENT AFFAIRS, INC. db7cc933-5894-4ca3-98f4-0006cfa3e0d0 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | SMITH & NEPHEW | 2025 | second_quarter | MED | Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations and authorization requests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-16T23:47:22-04:00 | |
| 3387198 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 3c9ae9c7-7993-4116-889a-89d99d08631e | 2A | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | THE GENEVA FOUNDATION | 2025 | second_quarter | MED | Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2025-07-17T00:01:08-04:00 | |
| 3387284 | CAPITOL COUNSEL LLC 1aa87fa8-8d83-44d7-b960-0bf81fa6311e | Q2 | CAPITOL COUNSEL LLC | 313715 | ALNYLAM PHARMACEUTICALS, INC. | 2025 | second_quarter | MED | Issues regarding FDA guidance on Platform Technology Platform Technology Designation Program for Drug Development. | Food & Drug Administration (FDA) | 30000 | 0 | 0 | 2025-07-17T06:42:21-04:00 | |
| 3387322 | TROUTMAN STATEGIES 96e1e0dc-74d2-4849-b390-02d46392ff53 | Q2 | TROUTMAN STATEGIES | 81511 | MURAL HEALTH | 2025 | second_quarter | MED | Issues related to taxing payments and reimbursements to participants in clinical trials. H. R. 4184 To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2025-07-17T08:03:16-04:00 | |
| 3387436 | CHIPPS, CAFFREY AND DUBILIER, P. S. C. f180eae3-4b72-4214-9fda-86c84aa0bfde | 2A | CHIPPS, CAFFREY AND DUBILIER, P. S. C. | 401108716 | CHIPPS, CAFFREY AND DUBILIER, P. S. C. | 2025 | second_quarter | MED | Lobbyed against medicaid cuts in the Big Beautiful Bill | HOUSE OF REPRESENTATIVES,SENATE | 9000 | 0 | 0 | 2025-07-17T09:20:31-04:00 | |
| 3387804 | CORNERSTONE GOVERNMENT AFFAIRS, INC. f4bc0ede-41f7-4a52-aeeb-342210bbc155 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CHILDREN'S NATIONAL MEDICAL CENTER | 2025 | second_quarter | MED | Health-related issues including reimbursement, research, public-health & clinical care. | Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2025-07-17T10:56:02-04:00 | |
| 3387937 | ASSOCIATION OF AMERICAN MEDICAL COLLEGES 1074ac09-62bc-4f5d-b91d-54d7d1ba4b80 | Q2 | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4493 | ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 2025 | second_quarter | MED | Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Oppose inappropriate use of march-in authority. Issue: Educate Congress and the administration about opportunities to strengthen medical research supported by National Institutes of Health (NIH). Issue: Provide input on proposed National Institutes of Health (NIH) optimization frameworks. H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support technical correction to ensure bill does not hamper the National Institutes of Health (NIH) peer review system. | Commerce, Dept of (DOC),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,White House Office | 831429 | 0 | 0 | 2025-07-17T11:23:44-04:00 | |
| 3387941 | MANATT, PHELPS, AND PHILLIPS cac6a873-8348-4fa3-b506-5843754de807 | Q2 | MANATT, PHELPS, AND PHILLIPS | 23645 | LOMA LINDA UNIVERSITY MEDICAL CENTER | 2025 | second_quarter | MED | Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF | 140000 | 0 | 0 | 2025-07-17T11:23:56-04:00 | ||
| 3387948 | MANATT, PHELPS, AND PHILLIPS 2f9ec433-f36f-4ee6-8dbc-f673a043f063 | Q2 | MANATT, PHELPS, AND PHILLIPS | 23645 | MEDISYS HEALTH NETWORK | 2025 | second_quarter | MED | Provider Relief and COVID funding and other healthcare issues; Community Project Funding | 40000 | 0 | 0 | 2025-07-17T11:24:58-04:00 | ||
| 3388145 | FOLEY & LARDNER LLP c7f35093-eb78-411a-9e7f-6c51ef06e064 | Q2 | FOLEY & LARDNER LLP | 15042 | CARDIAC RMS | 2025 | second_quarter | MED | Remote Cardiac Monitoring | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2025-07-17T11:55:45-04:00 | |
| 3388204 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c709cd3e-8a5e-45ad-b347-10a895e637df | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | DEFENSE HEALTH RESEARCH CONSORTIUM | 2025 | second_quarter | MED | HR 4016/S unnumbered, FY26 Defense Appropriations Act, Defense Health Research Programs; HR 3906, Medical Research For Our Troops Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-17T12:06:09-04:00 | |
| 3388307 | NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 2fbfa640-d59f-451d-ba26-e624f0f76ba8 | Q2 | NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH | 26557 | NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH | 2025 | second_quarter | MED | Need for continued biomedical research with animal models | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-17T12:17:57-04:00 | |
| 3388505 | FOLEY & LARDNER LLP e3eef568-06e7-4f38-ba10-31db2c1dc5ba | Q2 | FOLEY & LARDNER LLP | 15042 | PACIFIC EDGE DIAGNOSTICS USA | 2025 | second_quarter | MED | CMS Issue | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 20000 | 0 | 0 | 2025-07-17T12:58:42-04:00 | |
| 3388514 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4a07b789-c1a0-4f17-89c5-ad988577363b | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | PANCREATIC CANCER ACTION NETWORK (PANCAN) | 2025 | second_quarter | MED | HR 4016/S unnumbered, FY26 Defense Appropriations Act, Pancreatic Cancer Research Program; HR unnumbered/ S unnumbered, FY26 Labor HHS Education Appropriations Act, NIH research on pancreatic cancer | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-17T13:00:08-04:00 | |
| 3388533 | FOLEY & LARDNER LLP 27e54288-16ec-41b2-a859-0005f75af06d | Q2 | FOLEY & LARDNER LLP | 15042 | RHYTHM MANAGEMENT GROUP | 2025 | second_quarter | MED | Remote Cardiac Monitoring | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2025-07-17T13:03:18-04:00 | |
| 3388545 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f745d49e-9241-4673-b7dc-35686371bcb6 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | FOUNDATION FOR PERIPHERAL NEUROPATHY | 2025 | second_quarter | MED | HR 4016/S unnumbered, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for peripheral neuropathy; HR unnumbered/ S unnumbered, FY26 Labor HHS Education Appropriations Act, NIH research on peripheral neuropathy | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2025-07-17T13:04:55-04:00 | |
| 3388598 | FOLEY & LARDNER LLP 5c313e8b-3284-43e6-9f2a-a35e22688a4e | Q2 | FOLEY & LARDNER LLP | 15042 | VECTOR REMOTE CARE | 2025 | second_quarter | MED | Remote Cardiac Monitoring | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2025-07-17T13:14:55-04:00 | |
| 3388630 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ca093b79-0262-4fae-9aca-feb49feaaada | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2025 | second_quarter | MED | HR 4016/S unnumbered, FY26 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; HR unnumbered/ S unnumbered, FY26 Labor HHS Education Appropriations Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-17T13:20:01-04:00 | |
| 3388651 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 00cb163a-c91c-45e8-b141-ecda860824ee | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | KIDNEYCAN | 2025 | second_quarter | MED | HR unnumbered/S unnumbered, FY26 Labor HHS Education Act, kidney cancer research at NIH | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2025-07-17T13:22:05-04:00 | |
| 3388664 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. cde91611-0d15-4077-bd26-7ec562218c50 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | VHL ALLIANCE | 2025 | second_quarter | MED | HR 4016/S unnumbered, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Prgoram designation for VHL; HR unnumbered/ S unnumbered, FY26 Labor HHS Education Appropriations Act, NIH research on Von Hippel-Lindau syndrome | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2025-07-17T13:25:20-04:00 | |
| 3388935 | STRATEGIC MARKETING INNOVATIONS d941b8a3-ce52-47ca-aca3-43eb553a3faf | 2T | STRATEGIC MARKETING INNOVATIONS | 60550 | PREVENT BIOMETRICS | 2025 | second_quarter | MED | Defense appropriations for medical technology | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 1 | 2025-07-17T14:19:59-04:00 | |
| 3389422 | BALLARD PARTNERS c0d468b0-7606-476d-b0de-1447c9d22010 | Q2 | BALLARD PARTNERS | 401104288 | REVELLE AESTHETICS, INC. | 2025 | second_quarter | MED | Promoting the advancement of healthcare technology. | 200000 | 0 | 0 | 2025-07-17T15:15:45-04:00 | ||
| 3389611 | SIEMENS MEDICAL SOLUTIONS USA, INC b700f192-6113-4a23-a148-909de8dc8399 | Q2 | SIEMENS MEDICAL SOLUTIONS USA, INC | 401105966 | SIEMENS MEDICAL SOLUTIONS USA, INC | 2025 | second_quarter | MED | Issues related to NIH funding; and Issues related to ARPA-H Funding. | HOUSE OF REPRESENTATIVES,SENATE | 770000 | 0 | 0 | 2025-07-17T15:36:20-04:00 | |
| 3389811 | INVARIANT LLC 40571cc7-8036-4e95-a2e7-09ba9ddf5851 | Q2 | INVARIANT LLC | 314237 | NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS | 2025 | second_quarter | MED | Monitor policy and funding changes for NIH and pediatric research. | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2025-07-17T16:05:11-04:00 | |
| 3390232 | TERRAPOWER, LLC 0c3a05f4-07cc-4287-b4ff-23177d3aec8c | Q2 | TERRAPOWER, LLC | 401109474 | TERRAPOWER, LLC | 2025 | second_quarter | MED | Implementation of H.R. 3684, Infrastructure Investment and Jobs Act (IIJA); Implementation of H.R 5376 Inflation Reduction Act of 2022; Implementation of S. 870 - Fire Grants and Safety Act of 2023; Implementation of H.R.1042, Prohibiting Russian Uranium Imports Act; FY26 Appropriations, One Big Beautiful BillAct. | Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 225000 | 0 | 0 | 2025-07-17T17:11:02-04:00 | |
| 3390262 | TSG ADVOCATES DC, LLC 63a090cc-d265-4394-945a-5d8b8d0dff53 | 2A | TSG ADVOCATES DC, LLC | 401109292 | THE NEMOURS FOUNDATION | 2025 | second_quarter | MED | Healthcare and Medicaid | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2025-07-17T17:16:36-04:00 | |
| 3390672 | TRAVERE THERAPEUTICS d2c90ac0-b200-42cb-b14b-7376689fed21 | Q2 | TRAVERE THERAPEUTICS | 401104190 | TRAVERE THERAPEUTICS | 2025 | second_quarter | MED | HR 1262, S 932 Give Kids a Chance Act to renew PRV program; related provisions in H.R.1, One Big Beautiful Bill Act | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 200000 | 0 | 0 | 2025-07-17T19:20:32-04:00 | |
| 3390712 | STANFORD UNIVERSITY 194eaa0a-303f-46d0-bb75-11d4e8a1eeee | Q2 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2025 | second_quarter | MED | Policies with regard to indirect cost reimbursement rates at NIH | HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 0 | 2025-07-17T19:28:00-04:00 | |
| 3390741 | ALPINE GROUP PARTNERS, LLC. 8f2874ab-5598-4ee5-a8c1-eaafc74e3433 | Q2 | ALPINE GROUP PARTNERS, LLC. | 1171 | CARDIAC INSIGHT, INC. | 2025 | second_quarter | MED | Access to medical devices for heart screenings | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2025-07-17T19:32:21-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);